Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine

2010172 citationsJournal Articlehybrid Open Access

Authors

Yousuke Nakai · The University of Tokyo

Hiroyuki Isayama · The University of Tokyo

Hideaki Ijichi · The University of Tokyo

Takashi Sasaki · The University of Tokyo

Naoki Sasahira · The University of Tokyo

Kenji Hirano · The University of Tokyo

Hirofumi Kogure ·

Abstract

The ACEIs/ARBs in combination with gemcitabine might improve clinical outcomes in patients with advanced pancreatic cancer. Prospective trials are needed to test this hypothesis.

Topics & Keywords

Pancreatic and Hepatic Oncology Research Neuroendocrine Tumor Research Advances Renal cell carcinoma treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: British Journal of Cancer

Volume 103, Issue 11, pp. 1644-1648

DOI: 10.1038/sj.bjc.6605955

Field-Weighted Citation Impact: 4.69